SK288132B6 - A vaccine comprising lactobacilli for treating prostate inflammation and benign prostate hyperplasias - Google Patents

A vaccine comprising lactobacilli for treating prostate inflammation and benign prostate hyperplasias Download PDF

Info

Publication number
SK288132B6
SK288132B6 SK738-2002A SK7382002A SK288132B6 SK 288132 B6 SK288132 B6 SK 288132B6 SK 7382002 A SK7382002 A SK 7382002A SK 288132 B6 SK288132 B6 SK 288132B6
Authority
SK
Slovakia
Prior art keywords
strains
prostate
lactobacillus
vaccine
lactobacilli
Prior art date
Application number
SK738-2002A
Other languages
English (en)
Slovak (sk)
Other versions
SK7382002A3 (en
Inventor
Gyula Arpad Varga
Erika Agnes Lazar
Jozsef Bartus
Karoly Ujhelyi (Zomrel)
Original Assignee
Vakcina Kft.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Vakcina Kft. filed Critical Vakcina Kft.
Publication of SK7382002A3 publication Critical patent/SK7382002A3/sk
Publication of SK288132B6 publication Critical patent/SK288132B6/sk

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/02—Bacterial antigens
    • A61K39/09—Lactobacillales, e.g. aerococcus, enterococcus, lactobacillus, lactococcus, streptococcus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A61K35/74—Bacteria
    • A61K35/741—Probiotics
    • A61K35/744—Lactic acid bacteria, e.g. enterococci, pediococci, lactococci, streptococci or leuconostocs
    • A61K35/747—Lactobacilli, e.g. L. acidophilus or L. brevis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/08—Drugs for disorders of the urinary system of the prostate
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/52—Bacterial cells; Fungal cells; Protozoal cells
    • A61K2039/521—Bacterial cells; Fungal cells; Protozoal cells inactivated (killed)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/55—Medicinal preparations containing antigens or antibodies characterised by the host/recipient, e.g. newborn with maternal antibodies
    • A61K2039/552—Veterinary vaccine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A61K35/74—Bacteria
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/39—Medicinal preparations containing antigens or antibodies characterised by the immunostimulating additives, e.g. chemical adjuvants

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Molecular Biology (AREA)
  • Urology & Nephrology (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Endocrinology (AREA)
  • Reproductive Health (AREA)
  • Diabetes (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
SK738-2002A 1999-11-25 2000-11-23 A vaccine comprising lactobacilli for treating prostate inflammation and benign prostate hyperplasias SK288132B6 (sk)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
HU9904408A HU227086B1 (en) 1999-11-25 1999-11-25 Lactobacillus vaccine for treating prostata inflammatory and benign prostata hyperplasia
PCT/HU2000/000122 WO2001037862A2 (en) 1999-11-25 2000-11-23 A vaccine comprising lactobacilli for treating prostate inflammation and benign prostate hyperplasias

Publications (2)

Publication Number Publication Date
SK7382002A3 SK7382002A3 (en) 2002-11-06
SK288132B6 true SK288132B6 (sk) 2013-10-02

Family

ID=90014600

Family Applications (1)

Application Number Title Priority Date Filing Date
SK738-2002A SK288132B6 (sk) 1999-11-25 2000-11-23 A vaccine comprising lactobacilli for treating prostate inflammation and benign prostate hyperplasias

Country Status (20)

Country Link
US (4) US20080175865A1 (cs)
EP (1) EP1272216B1 (cs)
AT (1) ATE470452T1 (cs)
AU (1) AU779214B2 (cs)
CA (1) CA2394843C (cs)
CZ (1) CZ302662B6 (cs)
DE (1) DE60044539D1 (cs)
DK (1) DK1272216T3 (cs)
EA (1) EA005198B1 (cs)
ES (1) ES2348591T3 (cs)
HU (1) HU227086B1 (cs)
IL (2) IL149779A0 (cs)
PL (1) PL201804B1 (cs)
PT (1) PT1272216E (cs)
RO (1) RO122760B1 (cs)
RS (1) RS51201B (cs)
SI (1) SI20960B (cs)
SK (1) SK288132B6 (cs)
UA (1) UA78673C2 (cs)
WO (1) WO2001037862A2 (cs)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1723965A1 (en) 2005-05-18 2006-11-22 Stallergenes Sa Compositions for antigen-specific induction of immuno-tolerance via oral immunization
US9732131B2 (en) 2006-02-27 2017-08-15 Calviri, Inc. Identification and use of novopeptides for the treatment of cancer
US20110027348A1 (en) 2007-08-27 2011-02-03 Janos Feher Composition and method inhibiting inflammation
CA3065325A1 (en) 2017-06-02 2018-12-06 Arizona Board Of Regents On Behalf Of Arizona State University A method to create personalized cancer vaccines
US12025615B2 (en) 2017-09-15 2024-07-02 Arizona Board Of Regents On Behalf Of Arizona State University Methods of classifying response to immunotherapy for cancer
EP4038222A4 (en) 2019-10-02 2023-10-18 Arizona Board of Regents on behalf of Arizona State University METHODS AND COMPOSITIONS FOR IDENTIFYING NEOANTIGENS FOR USE IN THE TREATMENT AND PREVENTION OF CANCER

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CH639280A5 (de) * 1977-12-23 1983-11-15 Solco Basel Ag Verfahren zur herstellung einer vakzine gegen das trichomonas-syndrom.
DE19522472C2 (de) * 1995-06-21 1998-07-02 Eugen Baumgaertner Herstellungsverfahren eines Fermentationsproduktes zur Behandlung von Prostataleiden
CN1150314C (zh) * 1997-08-21 2004-05-19 纽西兰乳品局 增强免疫的乳酸菌
IT1298918B1 (it) * 1998-02-20 2000-02-07 Mendes Srl Uso di batteri dotati di arginina deiminasi per indurre apoptosi e/o ridurre una reazione infiammatoria e composizioni farmaceutiche
IT1306716B1 (it) * 1999-06-21 2001-10-02 Mendes S U R L Associazione di batteri lattici e suo uso per la prevenzione e/o iltrattamento terapeutico di infezioni e di stati infiammatori.

Also Published As

Publication number Publication date
ES2348591T3 (es) 2010-12-09
PT1272216E (pt) 2010-09-14
AU1874101A (en) 2001-06-04
US20180161414A1 (en) 2018-06-14
HUP9904408A2 (hu) 2002-03-28
IL149779A (en) 2009-05-04
UA78673C2 (en) 2007-04-25
YU37402A (sh) 2005-06-10
CZ302662B6 (cs) 2011-08-24
PL201804B1 (pl) 2009-05-29
RS51201B (sr) 2010-12-31
AU779214B2 (en) 2005-01-13
EA005198B1 (ru) 2004-12-30
US20080175865A1 (en) 2008-07-24
WO2001037862A3 (en) 2001-11-22
SI20960A (sl) 2003-02-28
CA2394843C (en) 2011-01-18
EP1272216B1 (en) 2010-06-09
US9056073B2 (en) 2015-06-16
PL355886A1 (en) 2004-05-31
HUP9904408D0 (en) 2000-01-28
US20110243990A1 (en) 2011-10-06
SI20960B (sl) 2011-01-31
SK7382002A3 (en) 2002-11-06
DE60044539D1 (de) 2010-07-22
IL149779A0 (en) 2002-11-10
CA2394843A1 (en) 2001-05-31
EP1272216A2 (en) 2003-01-08
RO122760B1 (ro) 2010-01-29
DK1272216T3 (da) 2010-09-27
HU227086B1 (en) 2010-06-28
CZ20021771A3 (cs) 2002-11-13
ATE470452T1 (de) 2010-06-15
US20160051657A1 (en) 2016-02-25
WO2001037862A2 (en) 2001-05-31
EA200200602A1 (ru) 2002-10-31

Similar Documents

Publication Publication Date Title
US20180161414A1 (en) Vaccine comprising lactobacillus strains for treating prostate inflammation and benign prostate hyperplasias
EP0681479B1 (en) Immunotherapeutic composition
US6391315B1 (en) Vaccine for inhibiting and preventing induced staphylococcus infection, isolated antigens used therein, and isolated antibodies induced thereby
JPH02503800A (ja) 炎症過程及びアレルギー性疾患の予防及び治療のための細菌性製剤
DE3686158T2 (de) Impfstoff gegen mastitis.
CN109512854A (zh) 用于预防和治疗过敏性鼻炎的益生菌组合物及基于其的鼻用制剂和制备方法
JP2000247895A (ja) 自己免疫疾患予防組成物
JPH05508407A (ja) パスツレラ・ムルトシダのトキソイドワクチン
Sayers et al. Possible lethal enhancement of toxins from putative periodontopathogens by nicotine: implications for periodontal disease.
JPH0149246B2 (cs)
RU2815387C1 (ru) Штамм бактерий Corynebacterium pseudotuberculosis, предназначенный для получения моно- или поливалентных иммуногенных композиций, направленных на специфическую профилактику казеозного лимфаденита (псевдотуберкулеза) мелкого рогатого скота
CN114903973B (zh) 一种呼吸道粘膜免疫增强药物组合物
MURATA et al. VIRULENCE AND IMMUNITY OF CORYNEBACTERIUM DIPHTHERIAE I. GENERAL PICTURES OF INFECTION AND IMMUNITY IN THE CONJUNCTIVAL DIPHTHERIA
Bertók et al. Nomenclature and significance of innate/natural immune mechanisms and of species specific resistance
Bizzini et al. Experimental and Clinical Results
Frappier et al. Some Biologic Properties of Mycobacteria following the Extraction of Lipids, The Power to Initiate Acquired Resistance
CA2154689C (en) Improved immunotherapeutic composition
Packard et al. THE PRESENT STATUS OF SERUM THERAPY.
JPS6267030A (ja) クロスリンクリシン含有マイコプラズマ性肺炎予防治療剤
CZ574889A3 (en) preparation for non-specific immunotherapy of domestic animals endomethritis and process for preparing thereof

Legal Events

Date Code Title Description
MM4A Patent lapsed due to non-payment of maintenance fees

Effective date: 20181123